Cedric O'Gorman, Chief Medical Officer at RELMADA THERAPEUTICS, INC. (RLMD), bought 10,000 shares at $3.18 ($32K) on 2023-05-23, disclosed to the SEC on 2023-05-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.